Evidence map›Paper›PMID 31766143›Full record

ArticleNutrients2019

Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects.

Carolina Ortega-Azorín, Oscar Coltell, Eva M Asensio, Jose V Sorlí, José I González, Olga Portolés, Carmen Saiz, Ramon Estruch, Judith B Ramírez-Sabio, Alejandro Pérez-Fidalgo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Carolina Ortega-AzorínDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-6719-9358
Oscar ColtellCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-4518-8495
Eva M AsensioDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0003-4558-0988
Jose V SorlíDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-0130-2006
José I GonzálezDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Olga PortolésDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Carmen SaizDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Ramon EstruchCIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0003-1260-4445
Judith B Ramírez-SabioOncology Department, Sagunto Hospital, 46250 Sagunto, Spain.
Alejandro Pérez-FidalgoDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.
Jose M OrdovasNutrition and Genomics Laboratory, JM-USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.ORCID 0000-0002-7581-5680
Dolores CorellaDepartment of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2366-4104
Universitat de València · ESHospital de Sagunto · ESInstituto de Salud Carlos III · ESTufts University · USUniversitat Jaume I · ES

Funding

Fundació La Marató de TV3 538/U/2016Generalitat Valenciana AEST/2018/044Generalitat Valenciana PROMETEO2017/017Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) CIBER 06/03Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) CNIC-06/2007Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI06/1326Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) PI07-0954Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economía y Competitividad-Fondo Europeo de Desarrollo Regional (FEDER) SAF2016-80532-RUniversity Jaume I COGRUP/2016/06University Jaume I P1-1B2013-54US Department of Agriculture, Agriculture Research Service 8050-51000-098-00D
6 · The paper itself

Abstract

Leptin is a hormone crucial in the regulation of food intake and body-weight maintenance. However, the genes and gene variants that influence its plasma levels are still not well known. Results of studies investigating polymorphisms in candidate genes have been inconsistent, and, in addition, very few genome-wide association studies (GWAS) have been undertaken. Our aim was to investigate the genes and gene variants most associated with plasma leptin concentrations in a high-cardiovascular-risk Mediterranean population. We measured plasma leptin in 1011 men and women, and analyzed the genetic factors associated using three approaches: (1) Analyzing the single nucleotide polymorphisms (SNPs) reported in a GWAS meta-analysis in other populations (including an SNP in/near each of these LEP, SLC32A1, GCKR, CCNL, COBLL1, and FTO genes); (2) Investigating additional SNPs in/near those genes, also including the RLEP gene; and (3) Undertaking a GWAS to discover new genes. We did not find any statistically significant associations between the previously published SNPs and plasma leptin (Ln) in the whole population adjusting for sex and age. However, on undertaking an extensive screening of other gene variants in those genes to capture a more complete set of SNPs, we found more associations. Outstanding among the findings was the heterogeneity per sex. We detected several statistically significant interaction terms with sex for these SNPs in the candidate genes. The gene most associated with plasma leptin levels was the FTO gene in men (specifically the rs1075440 SNP) and the LEPR in women (specifically the rs12145690 SNP). In the GWAS on the whole population, we found several new associations at the

Indexed as

Genetic Predisposition to DiseaseGenome-Wide Association StudyAgedCardiovascular DiseasesCross-Sectional StudiesFemaleGenetic MarkersHumansLeptinMaleMediterranean RegionPolymorphism, Single NucleotideSex FactorsSpainGenetic MarkersLeptingeneticsgenome-wide association studyheterogeneityleptinleptin receptorMediterranean populationobesitypolymorphismssex

Identifiers

PMID31766143
PMCPMC6893551
OpenAlexW2986773793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.